Clinical Trial Update: T-Cell Therapy (ECT204) in Adults With Advanced HCC [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of the T-cell therapy ECT204 for adults with advanced hepatocellular carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cancer
• Liver Neoplasm

Drugs mentioned

• ECT204

Snippet

Sponsor: Eureka Therapeutics Inc. | Conditions: Hepatocellular Carcinoma, Liver Cancer, Adult | Phase 1, Phase 2 | Status: RECRUITING